United States

Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

11:17am EDT
Change (% chg)

$0.78 (+1.64%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

M. James Barrett

74 2009 Independent Chairman of the Board

Patrick Mahaffy

54 2009 President, Chief Executive Officer, Director

Daniel Muehl

54 2016 Senior Vice President of Finance, Principal Accounting Officer and Principal Financial Officer

Gillian Ivers-Read

63 2009 Executive Vice President - Technical Operations, Chief Regulatory Officer

Lindsey Rolfe

49 2015 Executive Vice President - Clinical and Pre-Clinical Development and Pharmacovigilance and Chief Medical Officer